Dr. Madhu Lal-Nag

Program Director, Research Governance Council, Center for Drug Evaluation and Research, USFDA, USA

Talk by Dr. Madhu Lal-Nag

[Day 3]
09.30AM - 10.15 AM
Theme: Scientific Talk : Development of physiologically relevant disease platforms for therapeutic development

Personal Information

She is presently working as program Director for the Research Governance Council, the Center for Drug Evaluation and Research at the USFDA, USA. She has earned her Master’s in Biochemistry from the University of Mumbai, India and Master’s in Bioscience Business from The Keck Graduate Institute of Applied Biosciences, Claremont, CA. She has earned her Doctor of Philosophy (PhD) in Molecular and Cellular Oncology from The George Washington University. Her main passion lies in being able to bridge the gap between the academic and the translational aspects of cutting-edge science in oncology. Her research interests lie in the development of predictive alternative models for safety and efficacy in drug development and evaluation. Her work at the National Center for Advancing Translational Sciences (NCATS/NIH) focused on the development of single and multi-cellular tumour spheroids and organoids for high throughput small molecule and functional genomics screening. At NCATS, She served as the Director of the Trans NIH RNAi Facility that ran high throughput functional genomics screens for the entire NIH intramural program serving 21 institutes. She also led the formation of the first 3D standards working group, with InspheroInc, which comprised of a group of scientists representing the breadth of academia, pharma and government-run research institutions. She is very active in the micro physiological systems community continuing to teach workshops and give scientific talks about the role and intersection of alternative animal models and micro physiological systems in evaluating efficacy and safety of drugs in therapeutic development.

Download E-Certificate Rules & Regulations